Jul 15, 2026 05:13AM
Feb 12, 2026 03:37AM
Feb 12, 2026 03:37AM
Dec 18, 2025 06:33PM
Nov 12, 2024 07:01PM
Jul 9, 2024 07:13AM
Jan 22, 2024 04:30AM Sosei Heptares Webinar Presentation for FY2023 Financial Results
Nov 24, 2023 03:35AM
Aug 4, 2023 02:37AM
Jan 25, 2023 01:30AM
Jul 11, 2022 05:30AM
Feb 10, 2022 03:09AM
Jan 21, 2022 05:29AM
Nov 12, 2021 02:51AM Sosei Heptares Notes that its Partnered Adenosine A2a Antagonist Imaradenant (AZD4635) has been Removed from AstraZeneca's Clinical Pipeline
Nov 11, 2021 02:10AM
Aug 12, 2021 03:00AM
Jun 23, 2021 03:00AM
May 12, 2021 03:51AM
Feb 12, 2021 03:00AM
Jan 5, 2021 02:00AM
Nov 11, 2020 02:55AM Sosei Heptares Operational Highlights and Consolidated Results for the Nine Months ended 30 September 2020
Aug 13, 2020 03:52AM
Jun 5, 2020 03:18AM
May 1, 2020 02:48AM
Nov 28, 2019 04:02AM
Oct 1, 2019 03:00AM
Mar 21, 2019 07:50PM
Feb 2, 2018 06:19AM Sosei Announces Restatements of Previously Issued Quarterly and Full Year Accounts

1,208,834 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All